Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATFurniture, Fixtures and OtherLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

CytomX Therapeutics (CTMX) Shares Outstanding: 2014-2025

Historic Shares Outstanding for CytomX Therapeutics (CTMX) over the last 8 years, with Sep 2025 value amounting to $165.1 million.

  • CytomX Therapeutics' Shares Outstanding rose 111.00% to $165.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $165.1 million, marking a year-over-year increase of 111.00%. This contributed to the annual value of $80.1 million for FY2024, which is 19.00% up from last year.
  • CytomX Therapeutics' Shares Outstanding amounted to $165.1 million in Q3 2025, which was up 0.10% from $164.9 million recorded in Q2 2025.
  • CytomX Therapeutics' 5-year Shares Outstanding high stood at $165.1 million for Q3 2025, and its period low was $65.0 million during Q1 2021.
  • Moreover, its 3-year median value for Shares Outstanding was $78.1 million (2024), whereas its average is $89.3 million.
  • Data for CytomX Therapeutics' Shares Outstanding shows a peak YoY soared of 111.11% (in 2025) over the last 5 years.
  • CytomX Therapeutics' Shares Outstanding (Quarterly) stood at $65.4 million in 2021, then increased by 1.28% to $66.2 million in 2022, then climbed by 1.63% to $67.3 million in 2023, then climbed by 19.00% to $80.1 million in 2024, then spiked by 111.00% to $165.1 million in 2025.
  • Its Shares Outstanding was $165.1 million in Q3 2025, compared to $164.9 million in Q2 2025 and $80.6 million in Q1 2025.